Efficacy Results in Diagnostic Testing
Allow patients to remain euthyroid in diagnostic follow up using stimulated Tg Testing with or without a Whole-Body Scan
Comparing Thyrogen with THW in Tg Testing
Stimulated Tg versus non stimulated Tg testing
Approximately 1 in 5 metastatic disease positives were missed with non stimulated Tg testing1
Among patients with metastatic disease confirmed by a post treatment scan or by lymph node biopsy (35 patients), Thyrogen Tg was positive (≥2.5 ng/mL) in all 35 patients, while Tg on thyroid hormone suppressive therapy was positive (>2.5 ng/mL) in 79% of these patients.1
As with THW, the intrapatient reproducibility of Thyrogen testing with regard to both Tg stimulation and radio iodine imaging has not been studied.
Uptake comparable in whole body scan (WBS)
Choose how to get Thyrogen (Thyrotropin alfa) for your patients
Not sure which one to choose? Contact ThyrogenONE for assistance
Option 1: Sign up or log into the ThyrogenONE portal
The ThyrogenONE portal provides your office online access to help you and your patients :
Option 2: Call ThyrogenONE at 1-88-THYROGEN
Dedicated ThyrogenONE Case Managers can assist you and your patients with the following.